Comparaison de la biotolérance de l’huile extraite de l’arille de Blighia sapida (K. Koenig), des huiles de palme et d’olive chez le rat

Afin de valoriser l’huile extraite de l’arille de Blighia sapida, les effets  toxiques de cette huile ont été comparés aux effets toxiques possibles de deux huiles très consommées à travers le monde (huile d’olive et huile de palme). Cette étude s’est faite expérimentalement sur 54 rats mâles adultes de genre Albinos Wistar. Ces derniers ont été divisés en 9 groupes homogènes (6 par groupe) et ont reçu par gavage (2 fois par semaine pendant 4 semaines) les trois types d’huiles à trois volumes croissants 0,5mL ; 1mL ; 2mL. Tous les animaux ont survécu pendant la durée de l’expérimentation et les différents groupes ne présentaient apparemment pas de différence de signes cliniques. La comparaison des moyennes des paramètres hématologiques entre d’une part, les rats ayant reçu l’huilede palme et ceux ayant reçu l’huile extraite de l’arille de Blighia sapida et, d’autre part, entre les rats ayant reçu l’huile d’olive et ceux ayant reçu l’huile extraite de l’arille de Blighia sapida ne montrait pas de différence significative (p>0,05). Il en est de même pour la comparaison des moyennes des taux de triglycérides, de cholestérol Total, de  cholestérol-HDL et de bilirubines totale et conjuguée. Le taux de cholestérol et le ratio cholestérol montraient tous deux une élévation  significative (p<0,05) liée à l’administration d’huile de palme que l’administration d’huile extraite de l’arille de Blighia sapida, à partir de 1mL comme volume administré. Par contre, quel que soit le volume administré, le taux de cholesterol-LDL et le ratio cholestérol chez les rats ayant reçu l’huile extraite de l’arille de BHS était quasi-similaire à ceux des rats ayant reçu de l’huile d’olive (p>0,05). Comme ces huiles (huile d’olive et huile de palme) sont de consommation courante, alors, ces résultats ouvrent des perspectives intéressantes relatives à l’utilisation de l’huile extraite de l’arille de Blighia sapida en alimentation.Mots-clés : arille, huiles, effets toxiques, rats, gavage

Substitution de la farine de poisson par la farine d’asticots séchés dans le régime du rat en croissance : Risques pathologiques ?

Deux groupes de dix rats en croissance sont nourris durant 15 jours, avec deux régimes alimentaires ne différant que par la qualité de leurs protéines animales. L’un contient 10% de farine de poisson (témoin) et l’autre, 10% de farine d’asticots séchés (FAS). Le dosage des paramètres biochimiques plasmatiques et la biométrie des reins et des foies sont effectués chez tous les rats en fin d’expérience. Aucune pathologie ni anomalie physiologique n’a été décelée à travers les paramètres biochimiques plasmatiques. Mais, la biométrie des organes révèle chez les rats sous régime FAS, une diminution de 6,60% du poids des reins et une augmentation de 10,60% du poids des foies, en comparaison aux sujets témoins. Ces résultats pourraient présager une pathologie ou une perturbation du métabolisme nutritionnel de ces organes

Cholinergic and anticholinesterase activities of total protein extract of Morinda morindoïdes on isolated rabbit duodenum

Traditional herbal medicines such as Morinda morindoïdes are used for treatment of intestinal disorders including constipation in Ivory Coast. The aim of present study was to investigate the effect of total protein of Morinda morindoïdes extract (PT-Mm) on rabbit duodenum contractility and the involved possible mechanism(s). PT-Mm was extracted according to the saturation method of Dawson with ammonium sulfate. The cholinergic effect of the extract was determined by the in vitro organ bath method. The acetylcholinesterase (AChE) extracted from rabbit duodenum and it activity was determined by Ellman’s assay using acetylthiocholine (ASCh) as substrate. PT-Mm concentrations (40, 80, 120 and 200 μg/mL) showed dose-dependent effect a both tonicity and amplitude of the duodenum spontaneous contractions. The effective concentration which induces 50% effect of PT-Mm (EC50) was obtained with 68.57 ± 0.89 μg/mL. The antagonist tests carried out showed a considerable reduction (90%) in the amplitudes of duodenal contractions in the presence of atropine, but with nifedipine, the contractions were completely inhibited. PT-Mm also exerted non-competitive inhibition on AChE (Vmax = 5687 mM/min and KM = 578 μM). These results suggest that PT-Mm could stimulate duodenum smooth muscle contraction because it contains anti-AChE and cholinomimetic substances which, through muscarinic receptors, increase Ca2+ mobilization from extracellular. Therefore, PT-Mm could be used as a laxative, due to its stimulating effects on duodenal contractility.Keywords: Morinda morindoides, acetylcholinesterase, duodenum, contractio

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d\u27Ivoire

BackgroundA single co-administered dose of ivermectin (IVM) plus diethylcarbamazine (DEC) plus albendazole (ALB), or triple-drug therapy, was recently found to be more effective for clearing microfilariae (Mf) than standard DEC plus ALB currently used for mass drug administration programs for lymphatic filariasis (LF) outside of sub-Saharan Africa. Triple-drug therapy has not been previously tested in LF-uninfected individuals from Africa. This study evaluated the pharmacokinetics (PK), safety, and efficacy of triple-drug therapy in people with and without Wuchereria bancrofti infection in West Africa.MethodsIn this open-label cohort study, treatment-naïve microfilaremic (>50 mf/mL, n = 32) and uninfected (circulating filarial antigen negative, n = 24) adults residing in Agboville district, Côte d’Ivoire, were treated with a single dose of IVM plus DEC plus ALB, and evaluated for adverse events (AEs) until 7 days post treatment. Drug levels were assessed by liquid chromatography and mass spectrometry. Persons responsible for assessing AEs were blinded to participants’ infection status.FindingsThere was no difference in AUC0-inf or Cmax between LF-infected and uninfected participants (P>0.05 for all comparisons). All subjects experienced mild AEs; 28% and 25% of infected and uninfected participants experienced grade 2 AEs, respectively. There were no severe or serious adverse events. Only fever (16 of 32 versus 4 of 24, PConclusionsModerate to heavy W. bancrofti infection did not affect PK parameters for IVM, DEC or ALB following a single co-administered dose of these drugs compared to uninfected individuals. The drugs were well tolerated. This study confirmed the efficacy of the triple-drug therapy for clearing W. bancrofti Mf and has added important information to support the use of this regimen in LF elimination programs in areas of Africa without co-endemic onchocerciasis or loiasis.Trial registrationClinicalTrials.gov NCT02845713.</div

Investigation of rodent reservoirs of emerging pathogens in Côte d'Ivoire, West Africa

Background: One of the main health problems in West Africa remains upsurge of emerging pathogens. Ebola virus disease outbreak occurred in 2014 in Liberia, Guinea and Sierra Leone, Monkeypox virus in Nigeria in 2017 and most recently Lassa virus in Nigeria, Togo and Benin in 2018.&nbsp; These pathogens have animal reservoirs as vectors for transmission. Proper investigation of the pathogens in their rodent vectors could help&nbsp; reduce and manage their emergence and spread. Methodology: This study was conducted with an approval from the Côte d’Ivoire Bioethics Community. Small mammal trappings were carried out in&nbsp; 9 sites within three zones namely, peri-urban, peri-rural and protected areas. Liver, lung and kidney tissues from trapped small mammals were&nbsp; sampled in accordance with the recommended conditions of biosafety and bioethics. The organs were transported in liquid nitrogen to the&nbsp; laboratory. Molecular tests were used to detect pathogens. Orthopoxviruses and Monkeypox virus were detected in the organs by PCR using&nbsp; consensus primers targeting the virus surface membrane haemagglutinin (HA) genes, while Leptospira species were detected by PCR using primers&nbsp; targeting the rrs and lfb1 genes. Results: Out of 4930 night-traps, 256 (5.19%) small mammals were trapped including Crocidura, Rattus, Lophuromys, Praomys, Mus and Mastomys.&nbsp; Leptospira species were detected in 6 genera from 7 study sites and the infected small mammals accounted for 13.3%. Leptospira sp was detected&nbsp; mainly in the rodent vector genera Rattus (32.3%), Lophuromys (29.0%), and Praomys (16.1%). Three species of Leptospira were detected and&nbsp; Leptospira interrogans was the most common frequent species (74.2%). Monkeypox virus was not detected from studied small mammals. Conclusion: The initial data from our investigation indicates the presence of Leptospira sp in rodent vectors, Rattus, Lophuromys and Praomys,&nbsp; which are the potential small mammalian reservoirs of this pathogen in Cote d’Ivoire

Molecular diagnostics by PCR of poxviruses (Orthopoxvirus (OPV) and Molluscum contagiosum virus (MCV)) in Cote d'Ivoire West Africa

The Orthopoxvirus (OPV) and the Molluscum contagiosum virus (MCV) are Poxviruses involved in viruses skin lesions in humans. OPV infects many vertebrates and MCV mainly infects humans. A diagnostic confusion is often observed between the clinical lesions due to the different Poxviruses firstly and secondly with other viruses like the virus of the chickenpox. In Côte d'Ivoire, the diagnosis of MCV remains essentially clinical and that of OPV is non-existent despite the risk of circulation of the virus. This study aims to implementthe molecular detection of the OPV and the MVC in Côte d'Ivoire. Material and method: Cowpoxvirus DNA and 21 DNA extracts from suspicious cutaneous lesions of the MCV were analyzed by conventional PCR. The consensus primers (EACP1, EACP2) designed from the surface hemagglutin gene were used for the detection of the OPVs and the primers (MCV1, MCV2) targeting the K fragment of the MCV were used for the MCV’s detection . A growing dilution series of the Cowpoxvirus DNA and the MCV allowed the study of the method’s sensitivity used. The DNAs of S.aureus, M. ulcerans, VZV, HSV, the Measles virus and Varicella virus were used for the specificity tests. Results: The detection of the OPV from the Cowpoxvirus viral strain was positive with a positivity threshold at 10-1 dilution. That of the MCV DNA from the suspected MCV's lesion was positive with a positivity threshold of up to 10 -6 dilution. No non-specific amplification was observed with the DNAs of the other pathogens responsible for lesions Cutaneous. The clinical diagnosis of the MCV was confirmed by PCR in 18 out of the 21 patients, ie 85.71%. On the 3 patients with a negative MCV PCR, 2 were positive for the OPV PCR , reflecting the risk of confusion between clinical lesions due to Poxviruses.Keyvords: Molecular diagnostic, Poxviruses, West Afric